DNTH compared with CGON: revenue, margins and what each company keeps, and the suppliers and customers both name

DNTHDianthus Therapeutics, Inc.

Mkt capRevenueRevenue

CGONCG Oncology, Inc.

Mkt capRevenueRevenue

Compare

DNTHDianthus Therapeutics, Inc.

CGONCG Oncology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DNTH

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.7%▲+1.90%×0.20

May 6 '26±7.6%▲+0.20%×0.03

Q1 FY26±11.9%▲+21.52%×1.81

Jan 12 '26±9.0%▲+2.44%×0.27

CGON

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.5%▲+3.36%×0.23

May 8 '26±9.9%▲+0.64%×0.06

= impliedDNTH realized, solidCGON realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±10.7%

▲+4.79%

×0.45

Nov 14 '25±10.0%▲+8.61%×0.86

DNTHDianthus Therapeutics, Inc.

82.32▼−0.08%· post 82.32

Mkt cap$4.6BRevenue$761,000Q2 FY26Revenue$6MFY24

CGONCG Oncology, Inc.

62.03▼−4.10%· post 62.03

ClosedNov 2 '26

Mkt cap$5.7BRevenue$1MQ2 FY26Revenue—

Compare

ClosedNov 2 '26

DNTHDianthus Therapeutics, Inc.

CGONCG Oncology, Inc.

82.32▼−0.08%post 82.32

Price

62.03▼−4.10%post 62.03

$4.6B

Mkt cap

$5.7B

Q2 FY26$761,000

Revenue

$1MQ2 FY26

FY24$6M

Revenue

—

DNTH82.32▼−0.08%vsCGON62.03▼−4.10%ClosedNov 2 '26